Chiesi was awarded the 59° Oscar di Bilancio for the Benefit Corporation category

• The company has been awarded for its 2022 Sustainability Report, at Palazzo Mezzanotte in Milan, headquarters of Borsa Italiana.

Parma, December 18, 2023 – Chiesi, a research-oriented international biopharmaceutical group, was awarded the 59th Oscar di Bilancio for the Benefit Corporation category, sponsored by FERPI (Federazione Relazioni Pubbliche Italiana), Borsa Italiana and Bocconi University. The award ceremony entitled "Shared Value - The Future of Reporting is Written Today" was held at Palazzo Mezzanotte in Milan, headquarters of Borsa Italiana.

The Jury, chaired by Bocconi University Chancellor Francesco Billari and composed of the presidents of the sponsoring organizations and the 14 FERPI Partner Associations, reviewed the reports of the finalist companies and declared the winners for each of the 14 categories.

Chiesi's Sustainability Report was awarded because it represents a «comprehensive and well-integrated document in the areas of greatest relevance with clear representation and effective distribution between narrative and descriptive parts and methodological parts. It presents a process of planning and control of common benefit actions with a solid quantitative measurement framework».

"Sustainability is at the heart of Chiesi's strategy, which is embodied in the commitment of the approximately 7,000 people in the 31 countries where the company is present to create shared value for patients, communities, the environment and for all those who make up Chiesi today. A recognition, the Oscar di Bilancio, that makes us proud and invites us to continue decisively on our path towards transparent reporting, and constant measurement for continuous improvement that can really have a positive impact" - commented Giovanna Usvardi, Head of Global Communication & External Relations of Chiesi Group.

Born in 1954 with the aim of contributing to the development of consistent financial communication and the promotion of a culture of transparency, the Oscar di Bilancio has been endowed over the years with new Categories dealing with intangible value and value for the territory and society. Over the years, the award has added more and more elements from civil society, such as social enterprises and nonprofit associations, companies that are obliged by Legislative Decree No. 254/2016 to the Non-Financial Statement, Integrated reporting with all companies that make this reporting wanted with an international framework, etc.

About Chiesi Group

Chiesi is an international, research-focused biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment.

By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, we’re part of a global community of businesses that meet high standards of social and environmental impact. The company aims to reach Net-Zero greenhouse gases (GHG) emissions by 2035.

With over 85 years of experience, Chiesi is headquartered in Parma (Italy), operates in 31 countries, and counts more than 6,500 employees. The Group’s research and development centre in Parma works alongside 6 other important R&D hubs in France, the US, Canada, China, the UK, and Sweden.